Rensselaer Polytechnic Institute’s Georges Belfort, Ph.D., and Steven Cramer, Ph.D., both Institute Professors of Chemical and Biological Engineering, have won the 2025 Bernard M. Gordon Prize for Innovation in Engineering and Technology Education given by the National Academy of Engineering. 

Biotechnology researchers at Rensselaer Polytechnic Institute (RPI) are working to further improve mRNA therapeutics, with the aim of reducing manufacturing costs and enabling additional therapeutic uses for mRNA technology.

Bacteroides are essential bacteria in the human gut, playing a crucial role in our overall health. These microorganisms offer numerous benefits to their hosts, contributing to digestion and immune function. In their quest for survival, Bacteroides species are involved in fierce competition, employing mechanisms to interact and assert dominance. Certain Bacteroides species have developed ways to inject toxins into rival cells, showcasing their adaptability.

Rensselaer Polytechnic Institute (RPI) and the Icahn School of Medicine at Mount Sinai will offer a joint Ph.D. program in health sciences engineering beginning in the fall semester of 2025. RPI is a world-renowned technological research university known for its engineering, technology, and science programs. Icahn Mount Sinai is the academic arm of the Mount Sinai Health System, which includes eight hospitals and a vast network of ambulatory practices throughout the greater New York City region. The Ph.D.

Recently, RPI’s Richard Bonocora, Ph.D., senior lecturer in biological sciences, joined 29 other international participants for the Spaceflight Technology, Applications and Research (STAR) program. STAR is “a virtual NASA training for space biosciences.” The program, which will run until February, will give Bonocora an overview of the current topics in space biology, how to conduct an experiment in space and all of the unique considerations, and provide unique collaborative opportunities. He plans to share his new knowledge across campus with fellow faculty members as well as students. “I’m excited to gain knowledge through the STAR program that can help my students in many fields pursue these exciting opportunities,” said Bonocora.

A research study led jointly by Rensselaer Polytechnic Institute’s (RPI) Gaetano Montelione, Ph.D., Professor and Constellation Endowed Chair of Chemistry and Chemical Biology; and David Baker, Ph.D., professor of biochemistry, HHMI investigator, and the director of the Institute for Protein Design (IPD) at the University of Washington School of Medicine; describes a systematic high-throughput design approach for virtual screening and creation of novel polypeptide-based molecules that form regular secondary structures that can be used in biology or materials science research. Baker was recently named a co-recipient of the 2024 Nobel Prize in Chemistry for developing the emerging field of de novo protein design.

Rensselaer Polytechnic Institute’s Christopher Cioffi, Ph.D., Thomas and Constance D'Ambra Professor in Organic Chemistry, has been collaborating with Konstantin Petrukhin, Ph.D., Professor of Ophthalmic Science at Columbia University, to develop compounds to treat dry age-related macular degeneration (AMD) and Stargardt disease — both blindness-causing diseases.

Rensselaer Polytechnic Institute (RPI) has been awarded two grants by the National Institute on Aging (NIA) to train graduate students on Alzheimer’s disease (AD) research and commercialization. NIA is one of the National Institutes of Health in the U.S. Department of Health and Human Services and is the primary federal agency supporting and conducting AD research.